Barinthus Biotherapeutics plc. (BRNS) has 9 SEC Form 4 insider filings on record in the last 90 days. Most recent filing: Sept. 11, 2026.
| Date | Insider | Value | Shares | Stake | Pre-planned | Links |
|---|---|---|---|---|---|---|
| Sept. 11, 2026 filed Sept. 9, 2026 | Oxford Science Enterprises plc Insider | $976,552 | 8,797,770 | −100% | No | |
|
|
||||||
| Sept. 9, 2026 | Wright Robin Director | $0 | 180,469 | −100% | No | |
|
|
||||||
| Sept. 9, 2026 | Phillips Anne M. Director | $0 | 114,819 | −100% | No | |
|
|
||||||
| Sept. 9, 2026 | Scheeren Joseph Director | $0 | 134,819 | −100% | No | |
|
|
||||||
| Sept. 9, 2026 | Morgon Pierre A. Director | $0 | 142,719 | −100% | No | |
|
|
||||||
Showing the 5 most recent of 9 filings in the last 90 days.
Form 4 is the filing company officers, directors and 10% shareholders must submit to the SEC within two business days of trading their own company's stock. Open-market purchases generally carry more signal than sales, which are often scheduled in advance. More on how this works.
Real-time Telegram alerts the moment a Form 4 is filed. Filings shown here are delayed by 72 hours.
Start free